Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

957
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
957
Prevalence and Incidence01:08

Prevalence and Incidence

783
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
783
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral Treatment.

Cancers·2026
Same author

Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches.

Journal of medical virology·2026
Same author

The impact of pediatric influenza and COVID-19 hospitalization on parental attitudes toward vaccination.

Human vaccines & immunotherapeutics·2026
Same author

Towards elimination of viral hepatitis in the Czech Republic, Hungary, Poland and Slovakia: insights from the Viral Hepatitis Prevention Board (VHPB).

Clinical and experimental hepatology·2026
Same author

Prevalence of hearing loss and other ear disorders among patients with hepatitis B infection: a nationwide retrospective Polish cohort study.

Scientific reports·2026
Same author

Steatotic liver disease and chronic viral hepatitis.

Clinical and experimental hepatology·2026

相关实验视频

Updated: Sep 9, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.7K

病毒性肝炎感染负担和死亡率:2009-2023年波兰人口研究结果

Agnieszka Genowska1, Dorota Zarębska-Michaluk2, Michał Brzdęk3,4

  • 1Department of Public Health, Medical University of Bialystok, Bialystok, Poland.

Clinical and experimental hepatology
|September 4, 2025
PubMed
概括

COVID-19 流行病对波兰的病毒性肝炎趋势产生了重大影响,感染率和死亡率增加. 持续监测和加强预防对于消除病毒的努力至关重要.

关键词:
COVID-19 的影响流行病学感染情况死亡率病毒性肝炎的发展趋势

更多相关视频

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.5K

相关实验视频

Last Updated: Sep 9, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.7K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.5K

科学领域:

  • 流行病学
  • 传染性疾病
  • 公共卫生

背景情况:

  • 病毒性肝炎,包括A型肝炎 (HAV),B型肝炎 (HBV),C型肝炎 (HCV) 和E型肝炎 (HEV),对全球健康造成重大负担.
  • 了解长期流行病学趋势对于有效的公共卫生干预和疾病控制至关重要.

研究的目的:

  • 分析波兰病毒性肝炎感染和死亡率的流行病学模式和趋势.
  • 为了比较COVID-19疫情前和期间的趋势.

主要方法:

  • 使用了波兰2009-2023年病毒性肝炎 (HAV,HBV±HDV,HCV,HEV) 的国家注册数据.
  • 采用结合点回归模型来确定感染率和死亡率的重大趋势.

主要成果:

  • 波兰的病毒性肝炎负担在2009年至2023年间发生了显著变化.
  • 在2015年至2018年期间,HAV感染的显著增加.
  • 随着COVID-19大流行,大多数肝炎类型的感染率和死亡率有所增加,其他病毒性肝炎的发病率也明显增加.
  • 在整个研究期间,只有乙型肝炎病毒 (HBV) 感染的死亡率有所下降.

结论:

  • COVID-19 流行病对波兰的病毒性肝炎趋势产生了不利影响,可能阻碍了消除目标.
  • 持续监测病毒性肝炎感染和死亡趋势至关重要.
  • 需要加强预防措施,改善诊断和医疗连接,以应对日益增加的负担.